Related Videos
Video
ASCO22: Chris Manz, MD on AI in oncology
Artificial intelligence as a tool to increase discussions between patients and their oncology team about care goals can improve end-of-life care, according to research at led by Dana-Farber's Chris Manz, MD and presented at #ASCO22.